| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A large prospective study assessing injection site reactions, quality of life and preference in patients using the Biojector® vs standard needles for enfuvirtide administration *
|
Loutfy, MR
|
|
2007
|
|
7 |
p. 427-432
|
artikel
|
| 2 |
A randomized placebo-controlled trial of metformin for the treatment of HIV lipodystrophy
|
Kohli, R
|
|
2007
|
|
7 |
p. 420-426
|
artikel
|
| 3 |
A standardized, comprehensive magnetic resonance imaging protocol for rapid and precise quantification of HIV-1-associated lipodystrophy
|
Bickel, M
|
|
2007
|
|
7 |
p. 413-419
|
artikel
|
| 4 |
Estimating renal function in patients on tenofovir disoproxil fumarate: suggestions for safer use
|
Winston, J
|
|
2006
|
|
7 |
p. 484-485
|
artikel
|
| 5 |
Evaluation of hypophosphataemia in tenofovir disoproxil fumarate (TDF)-exposed and TDF-unexposed HIV-infected out-patients receiving highly active antiretroviral therapy
|
Buchacz, K
|
|
2006
|
|
7 |
p. 451-456
|
artikel
|
| 6 |
Increased serum lipids are associated with higher CD4 lymphocyte count in HIV-infected women
|
Floris-Moore, M
|
|
2006
|
|
7 |
p. 421-430
|
artikel
|
| 7 |
Longitudinal assessment (1995–2003) of hospitalizations of HIV-infected patients within a geographical population in Canada
|
Krentz, HB
|
|
2006
|
|
7 |
p. 457-466
|
artikel
|
| 8 |
Long-term assessment of nevirapine-containing highly active antiretroviral therapy in antiretroviral-naive HIV-infected patients: 3-year follow-up of the VIRGO study
|
Reliquet, V
|
|
2006
|
|
7 |
p. 431-436
|
artikel
|
| 9 |
Persistent low-level viraemia and virological failure in HIV-1-infected patients treated with highly active antiretroviral therapy
|
Sungkanuparph, S
|
|
2006
|
|
7 |
p. 437-441
|
artikel
|
| 10 |
Pharmacokinetics of oral zidovudine administered during labour: a preliminary study *
|
Mirochnick, M
|
|
2007
|
|
7 |
p. 451-456
|
artikel
|
| 11 |
Prevalence of protective antibody against measles in HIV-infected children with immune recovery after highly active antiretroviral therapy
|
Aurpibul, L
|
|
2006
|
|
7 |
p. 467-470
|
artikel
|
| 12 |
Prior antiretroviral therapy experience protects against zidovudine-related anaemia
|
Huffam, SE
|
|
2007
|
|
7 |
p. 465-471
|
artikel
|
| 13 |
Re-audit of patients initiating antiretroviral therapy
|
Curtis, H
|
|
2006
|
|
7 |
p. 486
|
artikel
|
| 14 |
Resistance development over 144 weeks in treatment-naive patients receiving tenofovir disoproxil fumarate or stavudine with lamivudine and efavirenz in Study 903 *
|
Margot, NA
|
|
2006
|
|
7 |
p. 442-450
|
artikel
|
| 15 |
Risk factors for death among patients in French Guiana: 1996–2005
|
Nacher, M
|
|
2007
|
|
7 |
p. 472-474
|
artikel
|
| 16 |
Serum leptin concentrations and fat redistribution in HIV-1-infected children on highly active antiretroviral therapy
|
Dzwonek, AB
|
|
2007
|
|
7 |
p. 433-438
|
artikel
|
| 17 |
Serum prostate-specific antigen levels in older men with or at risk of HIV infection
|
Vianna, LE
|
|
2006
|
|
7 |
p. 471-476
|
artikel
|
| 18 |
Steady-state pharmacokinetics of once-daily fosamprenavir/ritonavir and atazanavir/ritonavir alone and in combination with 20 mg omeprazole in healthy volunteers *
|
Luber, AD
|
|
2007
|
|
7 |
p. 457-464
|
artikel
|
| 19 |
The long-term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model-based approach
|
Yazdanpanah, Y
|
|
2007
|
|
7 |
p. 439-450
|
artikel
|
| 20 |
Transmitted drug-resistant HIV-1 in primary HIV-1 infection; incidence, evolution and impact on response to antiretroviral therapy
|
Fox, J
|
|
2006
|
|
7 |
p. 477-483
|
artikel
|
Tijdschrift beschrijving